Cardiovascular & Circulatory Health Support
Cardiovascular & Circulatory Health Support
Restoring flow. preserving vitality.
The cardiovascular system sustains every function in the body. When circulation declines — through inflammation, endothelial damage, or structural disease — tissues receive less oxygen, organs lose efficiency, and long-term resilience is compromised across all systems.
At Blast Institute, we approach cardiovascular health as an integrated network — from the heart to the smallest capillaries — guided by regenerative signals that restore flow, repair tissue, and support long-term vascular integrity.
Start Here
Take the First Step Toward Healthier Circulation
Speak with our team directly about your cardiovascular health and treatment options.
Share Your History
Tell us about your condition and goals.
Medical Review
Our team assesses whether therapy is right for you.
Personalized Protocol
Receive a plan built around your vascular health.
Speak With Us
Choose Your Call Time
A private, one-on-one call with our patient care team to discuss your condition and options.
Prefer to call? 1-858-868-4388
Why Patients Choose Blast Institute
-
Science-led team headed by Dr. Brigitte Hanly, with 20+ years in stem cell research
- Biologics developed and manufactured in-house at Blast Labs under controlled conditions
- Protocols tailored to your cardiovascular history and goals
- Treatment in a private setting in Baja California Sur
What Drives Cardiovascular Dysfunction
Endothelial Dysfunction
Damage to the inner lining of blood vessels impairs nitric oxide production, increases vascular stiffness, and initiates the inflammatory cascade underlying most cardiovascular disease.
Chronic Vascular Inflammation
Persistent low-grade inflammation drives plaque formation, arterial remodeling, and progressive narrowing — sustaining disease even when acute events are managed.
Microvascular Insufficiency
Impaired capillary function and reduced pericyte-endothelial coupling reduce oxygen delivery to tissues — a key driver of heart failure with preserved ejection fraction (HFpEF) and diabetic cardiomyopathy.
Structural Tissue Stress
Cardiac fibrosis, post-infarct scarring, and progressive loss of myocardial cells reduce pump function and limit the heart’s capacity for self-repair.
Pluripotent Stem Cells
PSC
Pluripotent Stem Cells
Cardiomyogenic factors – Anti-fibrotic – eNOS activation – Immunomodulation
Carry exosomal cargo relevant to all three germ layers, including cardiomyogenic factors, vascular stabilization signals, and immunomodulatory mediators. Adaptive signaling supports cardiac repair, reduces post-ischemic fibrosis, and restores endothelial function through mechanisms unavailable to lineage-restricted preparations.
EXOSOMAL
Pluripotent Exosomes
Pro-angiogenic – Anti-inflammatory – miRNA modulation -Microvascular repair
Highly concentrated vesicles carrying pro-angiogenic signals, anti-inflammatory mediators, and microRNAs that modulate vascular gene expression. Promote formation of new capillaries, reduce oxidative stress in vascular tissue, and enhance intercellular communication within the cardiac and vascular environment.
GENE THERAPY
Klotho Minicircle Therapy
Anti-calcification -Arterial integrity – Endothelial protection – 8–14 month effect
A longevity-associated protein with well-documented cardiovascular protective effects, delivered via non-viral minicircle DNA for sustained expression. Supports arterial integrity, reduces vascular calcification, maintains endothelial function, and protects against age-driven vascular stiffening. Effect duration: 8–14 months.
GENE THERAPY
FGF21 Minicircle Therapy
Fibroblast Growth Factor 21 is a primary metabolic hormone regulating glucose and lipid metabolism, enhancing insulin sensitivity, and improving cellular energy utilization. Delivered via minicircle DNA for 8–14 months of sustained expression, it addresses the hormonal deficit at the core of many metabolic conditions, particularly type 2 diabetes, metabolic syndrome, and obesity-related dysregulation.
GENE THERAPY
Follistatin Minicircle Therapy
Muscle preservation – Myostatin inhibition – Glucose disposal ↑ – 8–14 month effect
Follistatin promotes muscle mass and reduces adiposity by inhibiting myostatin, a negative regulator of muscle growth. Since skeletal muscle is the primary site of insulin-mediated glucose disposal, preserving and increasing muscle mass has a direct impact on insulin sensitivity and metabolic efficiency. Particularly relevant in metabolic syndrome, sarcopenic obesity, and age-related metabolic decline.
How the Cardiovascular Protocol Works
Terrain Preparation
Vascular inflammation and oxidative burden impair the penetration of regenerative signals. Ozone apheresis and IV antioxidant protocols reduce systemic inflammatory load prior to and during treatment — preparing the vascular environment for signaling to work.
Pulsed Daily Infusions
Each session introduces a fresh wave of cardiovascular-targeted regenerative signals. The adaptive nature of PSC exosomal output means each infusion is calibrated to the patient’s evolving physiological state — building progressively on the sessions before it.
Gene Therapy Extension (Optional)
Where indicated, a single administration of Klotho or VEGF-A minicircle therapy at program completion extends the vascular benefit for 8 to 14 months — sustaining endothelial support, angiogenesis, and anti-calcification signaling after the patient returns home.
Progressive Vascular Recovery
Cardiovascular repair — particularly in chronic and age-related presentations — unfolds over months. Measurable improvements in perfusion, exercise tolerance, and cardiac function develop progressively as cellular integration deepens and new vascular architecture matures.
Cardiovascular Conditions We Address
Heart Functions
Ischemic Heart Disease
Coronary · Perfusion · Chronic
Microvascular Applications
Coronary · Perfusion · Chronic
Diabetic Cardiomyopathy
Metabolic · Microvascular · CXCR4
Post-Myocardial Infarction Recovery
Acute · Fibrosis · Remodeling
Heart Failure & HFpEF
Microvascular · Diastolic · Function
Age-Related Vascular Decline
Longevity · Stiffness · Calcification
Vascular Health
Vascular Insufficiency
Peripheral · Arterial · Circulation
Endothelial Dysfunction
Nitric oxide · Arterial · Systemic
Scalp Revascularization
Hair · Microcirculation · Follicle support
From the heart to the smallest capillary — the entire vascular network is within reach of regenerative signaling. At Blast Institute, we design protocols that address cardiovascular dysfunction at its biological roots, restoring the flow and structural integrity on which every other system depends.
FAQs
What drives cardiovascular and circulatory dysfunction?
Cardiovascular dysfunction can involve endothelial stress, vascular inflammation, microvascular insufficiency and reduced circulation. BLAST Institute reviews these factors within a broader systemic health picture, including inflammation, metabolic burden and regenerative capacity, before building a personalized cardiovascular support protocol.
How does BLAST Institute approach cardiovascular and circulatory health support?
The approach starts with clinical assessment and patient-specific planning. Depending on the case, a protocol may include terrain preparation, pulsed regenerative support and tools described in the Clinical Methodology page, with the goal of supporting vascular and systemic health.
What regenerative tools may be considered for cardiovascular support?
A personalized cardiovascular protocol may consider pluripotent stem cells, pluripotent exosomes, Klotho or VEGF-A minicircle therapy and supportive interventions. These are selected case by case after review, rather than used as a fixed treatment package.